Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment ofPatients receiving Neoadjuvant Chemotherapy with Advanced-Stage Ovarian, Fallopian Tube or PrimaryPeritoneal Cancer who are Folate Receptor positive

Project: Research project

Project Details

Description

Single-Arm Phase II Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients receiving Neoadjuvant Chemotherapy with Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer who are Folate Receptor positive
StatusActive
Effective start/end date6/28/216/30/26

Funding

  • THE UNIVERSITY OF ALABAMA
  • IMMUNOGEN, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.